Medication info
Jadiwon Duo 5/500 mg

Jadiwon Duo 5/500 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
Orange-yellow, bilaterally convex, oval film-coated tablet
Packaging
60 tablets/bottle, 30 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]
Approval status
Active

MFDS item code 202201406 · Approved 2022.04.04 · Insurance code 698004710

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be given as this medicine is 1000 mg, which may be administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Medicine Is Contraindicated, item 2)). Older patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Abnormal blood sugar control
  • type 2 diabetes
  • cardiovascular diseases
View approved original text

This medication helps improve blood sugar control in adult patients with type 2 diabetes through the combined administration of empagliflozin and metformin. It is especially used as an adjunct to lifestyle modifications such as diet and exercise. Furthermore, for safety and effectiveness in patients with cardiovascular disease and type 2 diabetes, it is recommended to refer to professional clinical trial information. Overall, this medication plays an important role in improving blood sugar management and diabetes treatment.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be given as this medicine is 1000 mg, which may be administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Medicine Is Contraindicated, item 2)). Older patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication is primarily used for diabetes treatment and contains two ingredients that help regulate blood sugar levels. It may lead to a rare side effect known as severe lactic acidosis, which is a dangerous condition caused by excessive accumulation of lactic acid in the body. Patients with impaired kidney function, those with acute infections or dehydration, and those with cardiac diseases such as heart failure or acute myocardial infarction should not use this medication. Pregnant or breastfeeding women should also avoid taking this medication, and it should not be used by individuals allergic to its components. During the use of this medication, caution is needed as it may pose a risk of hypoglycemia when used in combination with other drugs that lower blood sugar. Additionally, since this medication is affected by kidney function, kidney function should be checked before starting and monitored regularly during treatment. Discontinuation of this medication is necessary for a certain period before and after procedures or examinations involving iodinated contrast agents, and it should be restarted only after kidney function has returned to normal. This medication may increase the risk of urinary tract infections or genital infections, so immediate consultation with healthcare providers is necessary if any symptoms of infection appear. Since vitamin B12 levels may decrease, monitoring of vitamin B12 concentrations is needed with long-term use. Alcohol consumption can increase the risk of side effects with this medication, so excessive drinking should be avoided during treatment. Elderly patients or those at risk for fluid loss should use this medication with particular caution, and if hypoglycemic symptoms or adverse reactions occur, they should notify healthcare providers immediately. Furthermore, no special blood sugar testing methods (such as 1,5-AG tests) are recommended during the use of this medication, apart from routine blood sugar control methods. The safety and efficacy of this medication have not been established in children, so it is advisable not to use it in individuals under 18 years of age. In case of overdose, blood dialysis may be required, so it is essential to adhere to the prescribed dosage and keep it out of reach of children.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 171 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • urticaria
  • erythema multiforme
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased serum creatinine
  • decreased glomerular filtration rate
  • nausea
  • vomiting
  • gastric ulcer
  • colitis
  • gastritis
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • dizziness
  • orthostatic dizziness
  • cerebral infarction
  • sensory loss
  • drowsiness
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinson's symptoms
  • polyneuropathy
  • drowsiness
  • weakness
  • chest discomfort
  • chest pain
  • fever
  • chills
  • strange sensations
  • edema
  • pain
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight loss
  • diarrhea
  • dyspepsia
  • abdominal pain
  • upper respiratory tract infection
  • bronchitis
  • soft tissue infection
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • appendiceal abscess
  • appendicitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • meningitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • herpes zoster
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal calcification
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina pectoris
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery obstructive disease
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • postural dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • hyperglycemia
  • dyslipidemia
  • hyponatremia
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • cervicitis
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • scrotal pain
  • sexual dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it is important to store it in a sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature, avoiding direct sunlight and placing it in a cool place.

Appearance and packaging

Appearance

Orange-yellow, bilaterally convex, oval film-coated tablet

Package unit

60 tablets/bottle, 30 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.